These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 15888272)

  • 1. [Preventive vaccines and immunotherapy clinical trials against cervical cancer].
    Valdespino-Gómez VM
    Cir Cir; 2005; 73(1):57-69. PubMed ID: 15888272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccines against human papillomavirus and cervical cancer: promises and challenges.
    Mahdavi A; Monk BJ
    Oncologist; 2005 Aug; 10(7):528-38. PubMed ID: 16079320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic human papillomavirus vaccines: current clinical trials and future directions.
    Hung CF; Ma B; Monie A; Tsen SW; Wu TC
    Expert Opin Biol Ther; 2008 Apr; 8(4):421-39. PubMed ID: 18352847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus vaccines for cervical cancer.
    Murakami M; Gurski KJ; Steller MA
    J Immunother; 1999 May; 22(3):212-8. PubMed ID: 10335480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer vaccines: progress and prospects.
    Steller MA
    J Soc Gynecol Investig; 2002; 9(5):254-64. PubMed ID: 12383909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination to prevent and treat cervical cancer.
    Roden RB; Ling M; Wu TC
    Hum Pathol; 2004 Aug; 35(8):971-82. PubMed ID: 15297964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines against human papillomavirus.
    Lin YY; Alphs H; Hung CF; Roden RB; Wu TC
    Front Biosci; 2007 Jan; 12():246-64. PubMed ID: 17127297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventative and therapeutic vaccines for cervical cancer.
    Roden R; Wu TC
    Expert Rev Vaccines; 2003 Aug; 2(4):495-516. PubMed ID: 14711335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies.
    Vici P; Pizzuti L; Mariani L; Zampa G; Santini D; Di Lauro L; Gamucci T; Natoli C; Marchetti P; Barba M; Maugeri-Saccà M; Sergi D; Tomao F; Vizza E; Di Filippo S; Paolini F; Curzio G; Corrado G; Michelotti A; Sanguineti G; Giordano A; De Maria R; Venuti A
    Expert Rev Vaccines; 2016 Oct; 15(10):1327-36. PubMed ID: 27063030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Vaccines Against Human Papilloma Viruses: Achievements and Prospects.
    Vonsky MS; Runov AL; Gordeychuk IV; Isaguliants MG
    Biochemistry (Mosc); 2019 Jul; 84(7):800-816. PubMed ID: 31509730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus vaccines for the prevention and treatment of cervical cancer.
    Tomson TT; Roden RB; Wu TC
    Curr Opin Investig Drugs; 2004 Dec; 5(12):1247-61. PubMed ID: 15648945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research.
    Lee SJ; Yang A; Wu TC; Hung CF
    J Gynecol Oncol; 2016 Sep; 27(5):e51. PubMed ID: 27329199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses against virus and tumor in cervical carcinogenesis: treatment strategies for avoiding the HPV-induced immune escape.
    Conesa-Zamora P
    Gynecol Oncol; 2013 Nov; 131(2):480-8. PubMed ID: 23994536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus immunogen that provides protective tumor immunity and induces tumor regression.
    Marquez JP; Rivera R; Kang KH; Gardner MB; Torres JV
    Viral Immunol; 2012 Apr; 25(2):141-52. PubMed ID: 22486305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Approaches Target to Immunotherapy for HPV-Associated Cancers.
    Zhang L; Zhou F; Zhao KN
    Curr Cancer Drug Targets; 2017; 17(6):512-521. PubMed ID: 27993116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV vaccines.
    Stanley M
    Best Pract Res Clin Obstet Gynaecol; 2006 Apr; 20(2):279-93. PubMed ID: 16356772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Jenkins D
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA vaccines for cervical cancer: from bench to bedside.
    Hung CF; Monie A; Alvarez RD; Wu TC
    Exp Mol Med; 2007 Dec; 39(6):679-89. PubMed ID: 18160838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in dendritic-cell-based therapeutic vaccines for cervical cancer.
    Bellone S; Pecorelli S; Cannon MJ; Santin AD
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1473-86. PubMed ID: 17944571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillomavirus-like particle vaccines for cervical cancer.
    Schiller JT
    Mol Med Today; 1999 May; 5(5):209-15. PubMed ID: 10322313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.